Molecular Docking Study of Gingkgo biloba Compounds as Potential Inhibitors of SARS-CoV-2

Molecular Docking Study of Gingkgo biloba Compounds as Potential Inhibitors of SARS-CoV-2

COVID-19 pandemic caused by SARS-CoV-2 is a challenge for researchers to find effective drugs for this disease. Previous research had identified the role of Mpro, TMPRSS2, RdRp, and ACE2 which were useful as promising drug targets to inhibit SARS-CoV-2. This study aims to identify the potential comp...

Full description

Bibliographic Details
Main Authors: Putri Mahirah Afladhanti, Muhammad Despriansyah Romadhan, Haidar Ali Hamzah, Safa Nabila Putri, Ellen Callista Angelica
Format: Article
Language:English
Published: Talenta Publisher 2022-09-01
Series:Scripta Score Scientific Medical Journal
Subjects:
bilobetin
ginkgo biloba
ginkgolide-c
sars-cov-2
Online Access:https://talenta.usu.ac.id/scripta/article/view/8399

Similar Items

Similar Items